Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2025)